Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to Anoikis

被引:123
作者
Yi, Jing [1 ]
Cai, Jun [1 ]
Niu, Xin [1 ]
Chen, Yuying [1 ]
Hu, Qingshen [1 ]
Shi, Guiying [1 ]
Wu, Huacheng [1 ]
Wang, Jian [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Cell Biol, Shanghai 200025, Peoples R China
来源
NEOPLASIA | 2008年 / 10卷 / 01期
基金
中国国家自然科学基金;
关键词
D O I
10.1593/neo.07754
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
RhoA is a critical signaling molecule regulating a variety of cellular processes, such as cytoskeletal organization, adhesion, and apoptosis. It is recently considered responsive to reactive oxygen species (ROS). Nevertheless, how RhoA regulates anoikis, a detachment-initiated apoptosis, and how this regulation is affected by ROS are not clear. The present study investigated the role of RhoA in apoptosis/anoikis in gastric cancer cells and the changes of RhoA and anoikis under oxidative stress. Immunohistochemistry showed that RhoA expression was upregulated in the primary gastric carcinoma compared with normal gastric mucosa. Overactivation of RhoA by transfection with the V14RhoA mutant prevented gastric cancer line SGC-7901 cells from arsenic-induced apoptosis and conferred anoikis resistance through, at least in part, promoting formations of F-actin fibers and focal adhesion. Oxidative stress caused by emodin, an ROS producer, in combination with arsenic trioxide (ATO) led to RhoA inactivation that triggered structural disruption of focal adhesion complex and eventually resulted in anoikis, and these effects could be partially reversed by antioxidant N-acetylcysteine (NAC). In conclusion, activation of RhoA is required for the maintenance of anoikis resistance phenotype of gastric cancer cells, and oxidative stress might be a therapeutic strategy for the inhibition of RhoA in cancer cells.
引用
收藏
页码:41 / 51
页数:11
相关论文
共 56 条
[1]
Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method [J].
Aida, Junko ;
Izumiyama-Shimomura, Naotaka ;
Nakamura, Ken-ichi ;
Ishii, Akio ;
Ishikawa, Naoshi ;
Honma, Naoko ;
Kurabayashi, Rie ;
Kammori, Makoto ;
Poon, Steven S. S. ;
Arai, Tomio ;
Takubo, Kaiyo .
HUMAN PATHOLOGY, 2007, 38 (08) :1192-1200
[2]
The integrin-linked kinase (ILK) suppresses anoikis [J].
Attwell, S ;
Roskelley, C ;
Dedhar, S .
ONCOGENE, 2000, 19 (33) :3811-3815
[3]
Rho GTPases:: potential candidates for anticancer therapy [J].
Aznar, S ;
Fernández-Valerón, P ;
Espina, C ;
Lacal, JC .
CANCER LETTERS, 2004, 206 (02) :181-191
[4]
Paxillin: Adapting to change [J].
Brown, MC ;
Turner, CE .
PHYSIOLOGICAL REVIEWS, 2004, 84 (04) :1315-1339
[5]
Treatment of acute promyelocytic leukemia with arsenic compounds: In vitro and in vivo studies [J].
Chen, Z ;
Chen, GQ ;
Shen, ZX ;
Chen, SJ ;
Wang, ZY .
SEMINARS IN HEMATOLOGY, 2001, 38 (01) :26-36
[6]
Regulation of anoikis by Cdc42 and Rac1 [J].
Cheng, TL ;
Symons, M ;
Jou, TS .
EXPERIMENTAL CELL RESEARCH, 2004, 295 (02) :497-511
[7]
Function of Rho family proteins in actin dynamics during phagocytosis and engulfment [J].
Chimini, G ;
Chavrier, P .
NATURE CELL BIOLOGY, 2000, 2 (10) :E191-E196
[8]
Rho GTPase signalling pathways in the morphological changes associated with apoptosis [J].
Coleman, ML ;
Olson, MF .
CELL DEATH AND DIFFERENTIATION, 2002, 9 (05) :493-504
[9]
Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system [J].
Dai, J ;
Weinberg, RS ;
Waxman, S ;
Jing, YK .
BLOOD, 1999, 93 (01) :268-277
[10]
Metastasis: recent discoveries and novel treatment strategies [J].
Eccles, Suzanne A. ;
Welch, Danny R. .
LANCET, 2007, 369 (9574) :1742-1757